A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
Public ClinicalTrials.gov record NCT03859869. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Creon (Pancrelipase) Therapy for Subjects With Exocrine Pancreatic Insufficiency (EPI) Due to Pancreatic Cancer: A Double-blind, Randomized, Parallel Design With 2 Dose Cohorts of Pancrelipase in Resected Pancreatic Cancer Subjects and an Open-label Single Dose Cohort in Non-resected Pancreatic Cancer Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study in participants with Exocrine Pancreatic Insufficiency (EPI) due to pancreatic cancer. This study will include resected participants who are post pancreatic cancer surgery, and an additional cohort in non-resected participants.
Study identification
- NCT ID
- NCT03859869
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1 participant
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2020 (Actual)
- Primary completion
- Mar 23, 2022 (Actual)
- Completion
- Mar 23, 2022 (Actual)
- Last update posted
- Jun 5, 2023
2020 – 2022
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Oncology /ID# 207770 | Birmingham | Alabama | 35223-2437 | — |
| Banner University of Arizona Medical Center Phoenix /ID# 208402 | Phoenix | Arizona | 85006 | — |
| UCSF Fresno /ID# 205757 | Fresno | California | 93701-2302 | — |
| Stanford University School of Med /ID# 208821 | Stanford | California | 94305-2200 | — |
| UCH-MHS Memorial Hospital Central /ID# 207093 | Colorado Springs | Colorado | 80909-4533 | — |
| UCHealth Cancer Care and Hematology Clinic /ID# 207091 | Fort Collins | Colorado | 80528-3400 | — |
| George Washington University Medical Faculty Associates /ID# 203363 | Washington D.C. | District of Columbia | 20037-3201 | — |
| University of Florida - Archer /ID# 202679 | Gainesville | Florida | 32610 | — |
| Columbus Regional Research Institute /ID# 211394 | Columbus | Georgia | 31904-8915 | — |
| Northwest Community Hospital /ID# 202270 | Arlington Heights | Illinois | 60005-2355 | — |
| NorthShore University HealthSystem /ID# 209026 | Evanston | Illinois | 60201 | — |
| Ingalls Memorial Hosp /ID# 203962 | Harvey | Illinois | 60426 | — |
| Advocate Christ Medical Center /ID# 203132 | Oak Lawn | Illinois | 60453-2600 | — |
| University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 204407 | Ann Arbor | Michigan | 48109 | — |
| Ascension Providence Hospital /ID# 203449 | Southfield | Michigan | 48075-4825 | — |
| St. Louis University /ID# 205769 | St Louis | Missouri | 63104 | — |
| Mercy Hospital South /ID# 221766 | St Louis | Missouri | 63128 | — |
| Northwell Health Center for Liver Diseases /ID# 207321 | Manhasset | New York | 11030-3815 | — |
| NYU Winthrop Hospital /ID# 207513 | Mineola | New York | 11501 | — |
| New York University Langone Me /ID# 202290 | New York | New York | 10016 | — |
| Columbia University Medical Center /ID# 204165 | New York | New York | 10032-3729 | — |
| East Carolina University /ID# 206661 | Greenville | North Carolina | 27858 | — |
| Gabrail Cancer Center Research /ID# 208030 | Canton | Ohio | 44718 | — |
| Ohio State Cancer Center /ID# 203131 | Columbus | Ohio | 43210 | — |
| Fox Chase Cancer Center /ID# 202288 | Philadelphia | Pennsylvania | 19111 | — |
| Reading Hospital /ID# 206869 | Reading | Pennsylvania | 19611 | — |
| Musc /Id# 210727 | Charleston | South Carolina | 29425 | — |
| Tennessee Cancer Specialists /ID# 208235 | Knoxville | Tennessee | 37909 | — |
| Vanderbilt University Medical Center /ID# 204231 | Nashville | Tennessee | 37232-0011 | — |
| Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 206156 | Dallas | Texas | 75246-2003 | — |
| UT MD Anderson Cancer Center /ID# 202271 | Houston | Texas | 77030 | — |
| Wisconsin Center for Advanced Research, a division of GI Associates, LLC /ID# 205746 | Milwaukee | Wisconsin | 53215 | — |
| Medical College of Wisconsin /ID# 205714 | Milwaukee | Wisconsin | 53226-3522 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03859869, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03859869 live on ClinicalTrials.gov.